Your browser doesn't support javascript.
loading
Interim analysis from a phase 2 randomized trial of EuCorVac-19: a recombinant protein SARS-CoV-2 RBD nanoliposome vaccine.
Lovell, Jonathan F; Baik, Yeong Ok; Choi, Seuk Keun; Lee, Chankyu; Lee, Jeong-Yoon; Miura, Kazutoyo; Huang, Wei-Chiao; Park, Young-Shin; Woo, Sun-Je; Seo, Sang Hwan; Kim, Jae-Ouk; Song, Manki; Kim, Chung-Jong; Choi, Jae-Ki; Kim, Jieun; Choo, Eun Ju; Choi, Jung-Hyun.
Afiliación
  • Lovell JF; Department of Biomedical Engineering, University at Buffalo, Buffalo, NY, USA. jflovell@buffalo.edu.
  • Baik YO; Eubiologics, R&D Center, EuBiologics Co., Ltd., Chuncheon, South Korea.
  • Choi SK; Eubiologics, R&D Center, EuBiologics Co., Ltd., Chuncheon, South Korea.
  • Lee C; Eubiologics, R&D Center, EuBiologics Co., Ltd., Chuncheon, South Korea.
  • Lee JY; Eubiologics, R&D Center, EuBiologics Co., Ltd., Chuncheon, South Korea.
  • Miura K; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
  • Huang WC; Department of Biomedical Engineering, University at Buffalo, Buffalo, NY, USA.
  • Park YS; POP Biotechnologies, Buffalo, NY, USA.
  • Woo SJ; International Vaccine Institute, Gwanak-Gu, Seoul, South Korea.
  • Seo SH; International Vaccine Institute, Gwanak-Gu, Seoul, South Korea.
  • Kim JO; International Vaccine Institute, Gwanak-Gu, Seoul, South Korea.
  • Song M; International Vaccine Institute, Gwanak-Gu, Seoul, South Korea.
  • Kim CJ; International Vaccine Institute, Gwanak-Gu, Seoul, South Korea.
  • Choi JK; Department of Internal Medicine, Ewha Womans University Seoul Hospital, Seoul, South Korea.
  • Kim J; Catholic University of Korea, Bucheon St. Mary's Hospital, Bucheon, South Korea.
  • Choo EJ; Hanyang University College of Medicine, Seoul, South Korea.
  • Choi JH; Soonchunhyang University Bucheon Hospital, Bucheon, South Korea.
BMC Med ; 20(1): 462, 2022 11 30.
Article en En | MEDLINE | ID: mdl-36447243

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Aged / Humans / Middle aged Idioma: En Revista: BMC Med Asunto de la revista: MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Aged / Humans / Middle aged Idioma: En Revista: BMC Med Asunto de la revista: MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido